A novel 3D printed bioactive scaffolds with enhanced osteogenic inspired by ancient Chinese medicine HYSA for bone repair.
Alginates
/ pharmacology
Alkaline Phosphatase
/ metabolism
Animals
Bone Regeneration
/ drug effects
Calcification, Physiologic
/ drug effects
Cell Movement
/ drug effects
Cell Proliferation
/ drug effects
Chalcone
/ analogs & derivatives
Chitosan
/ pharmacology
Gene Expression Regulation
/ drug effects
Human Umbilical Vein Endothelial Cells
/ drug effects
Humans
Male
Mesenchymal Stem Cells
/ cytology
Neovascularization, Physiologic
/ drug effects
Osteogenesis
/ drug effects
Printing, Three-Dimensional
Rats, Sprague-Dawley
Tissue Scaffolds
/ chemistry
X-Ray Diffraction
X-Ray Microtomography
Angiogenesis
Bioactive glass
Chinese medicine
Hydroxy-safflower yellow A(HYSA)
Osteogenesis
Journal
Experimental cell research
ISSN: 1090-2422
Titre abrégé: Exp Cell Res
Pays: United States
ID NLM: 0373226
Informations de publication
Date de publication:
15 09 2020
15 09 2020
Historique:
received:
22
04
2020
revised:
13
05
2020
accepted:
07
06
2020
pubmed:
21
6
2020
medline:
28
1
2021
entrez:
21
6
2020
Statut:
ppublish
Résumé
Some traditional Chinese medicine (TCM) has been applied in bone repair, however, hydroxy-safflower yellow A (HYSA), one composition of safflower of the typical invigorating the circulation of TCM, has little been studied in orthopedics field for osteogenesis and angiogenesis clinically. Herein, we hypothetically speculated that the synthetic bioactive glasses (BG, 1393) scaffolds carried HYSA by a 3D print technique could enhance osteogenic repair properties. Notably, scaffolds coating chitosan/sodium alginate endowed with excellent drug control release ability, and significantly improved the BG mechanical strength. HYSA was loaded into BG scaffolds by coating chitosan/sodium alginate film, and the osteogenesis and angiogenesis of the HYSA/scaffolds were evaluated in vitro and in vivo. In vitro the cell culture results exhibited that the high dose of HYSA (0.5 mg/ml) loaded scaffolds can promote the proliferation of bone marrow stromal cells (rBMSCs) and migration, tubule formation of human umbilical vein endothelial cells (HUVECs). The active alkaline phosphatase (ALP) of rBMSCs can also be improved by the high dose of HYSA/scaffolds. Results of qRT-PCR and Western blot indicated that the high dose of HYSA/scaffolds can up-regulate ALP, OCN, OPN and RUNX-2 expression and relative protein secretion of the HIF-1α and BMP-2. In the animal experiment, the high dose of HYSA/scaffolds has a significantly better capacity to promote new bone formation than the undoped scaffolds at 8 weeks post-surgery. Thus, our results claimed that the novel HYSA/scaffolds hold the substantial potential to be further developed as effective and safe bone tissue engineering biomaterials for bone regeneration by combining enhanced osteogenesis and angiogenesis.
Identifiants
pubmed: 32562783
pii: S0014-4827(20)30386-4
doi: 10.1016/j.yexcr.2020.112139
pii:
doi:
Substances chimiques
Alginates
0
safflower yellow
1401-20-3
Chalcone
5S5A2Q39HX
Chitosan
9012-76-4
Alkaline Phosphatase
EC 3.1.3.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
112139Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.